In Figure 5A and the IL-4 levels were observed in the following groups: the control group (10.51 ± 2.99 pg/mL), the American cutaneous leishmaniasis group (8.33 ± 0.65 pg/mL), the type 2 diabetes mellitus group (9.62 ± 0.62 pg/mL), and the group with both American cutaneous leishmaniasis and type 2 diabetes mellitus (9.40 ± 1.26 pg/mL). The gene discussed is IL4; the disease is type 2 diabetes mellitus.